Sage Journals: Discover world-class research

Abstract

Background

Low vitamin D status is associated with increased risk of cardiovascular disease and may be involved in atherosclerosis. Our aim was to assess the association between vitamin D status and the progression of coronary artery disease (CAD).

Methods and Results

We measured 25-hydroxyvitamin D3 (25OHD3) by liquid chromatography tandem mass spectrometry (LC-MS/MS) in plasma from 348 participants with established CAD (84% males, mean ± standard deviation (SD) age 60 ± 10 years) of the Western Norway B-vitamin Intervention Trial (WENBIT, 1999–2006). The patients underwent invasive coronary angiography (CA) and percutaneous coronary intervention at baseline and a second CA after 302 ± 79 days of follow-up. From the angiograms, minimal lumen diameter (MLD) and diameter stenosis (DS) of atherosclerotic lesions were obtained. Significant CAD in non-intervened vessels was found in 309 coronary arteries from 183 participants either at baseline and/or at follow-up. To assess the association between levels of 25OHD3 and CAD progression in non-intervened vessels, we applied a linear quantile fitted mixed effects model with MLD or DS measured at follow-up as a function of continuous 25OHD3 concentrations.

There were no statistically significant associations between plasma 25OHD3 concentrations (median: 63.9, 95% confidence interval (CI): 48.1–78.5 nmol/l) measured at baseline and the follow-up measures of either MLD (estimated effect per 10 nmol/l increase of 25OHD3 and 95% CI: –0.015 (−0.032–0.002) mm, p = 0.088) or DS (0.225 (−0.354–0.804) percentage points, p = 0.444). Multivariate adjustment did not alter these results.

Conclusion

Plasma 25OHD3 levels were not associated with ‘one-year’ progression of CAD, assessed by CA in statin-treated patients.

Keywords

Vitamin D 25-hydroxyvitamin D calcifediol coronary artery disease atherosclerosis disease progression coronary angiography

Get full access to this article

View all access options for this article.

References

Lozano

Naghavi

Foreman

. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095–2128.

Murray

CJL

Vos

Lozano

. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197–2223.

Rose

. Cold weather and ischaemic heart disease. Br J Prev Soc Med 1966; 20: 97–100.

Hopstock

Wilsgaard

Njolstad

. Seasonal variation in incidence of acute myocardial infarction in a sub-Arctic population: The Tromso Study 1974–2004. Eur J Cardiovasc Prev Rehabil 2011; 18: 320–325.

Ross AC and Institute of Medicine (US). Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary reference intakes: Calcium, vitamin D , Washington, DC: National Academies Press, 2011, pp. xv, 536, 1115–xv, 536, 1115.

Lips

. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007; 103: 620–625.

Wang

Pencina

Booth

. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503–511.

Dobnig

Pilz

Scharnagl

. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340–1349.

Giovannucci

Liu

Hollis

. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008; 168: 1174–1180.

10.

Koeffler

Amatruda

Ikekawa

. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 1984; 44: 5624–5628.

11.

Merke

Hofmann

Goldschmidt

. Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 1987; 41: 112–114.

12.

Merke

Milde

Lewicka

. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989; 83: 1903–1915.

13.

Mitsuhashi

Morris

RC Jr

Ives

. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991; 87: 1889–1895.

14.

Kuroki

. Possible functions of 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3, in the differentiation and development of skin. J Invest Dermatol 1985; 84: 459–460.

15.

Welsh

. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 1994; 72: 537–545.

16.

Bouillon

Carmeliet

Verlinden

. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726–776.

17.

Ebbing

Bleie

Ueland

. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA 2008; 300: 795–804.

18.

Loland

Bleie

Blix

. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: A Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol 2010; 105: 1577–1584.

19.

Løland

Bleie

Borgeraas

. The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. PloS One 2013; 8: e64774–e64774.

20.

Austen

Edwards

Frye

. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 5–40.

21.

Midttun

Ueland

. Determination of vitamins A, D and E in a small volume of human plasma by a high-throughput method based on liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2011; 25: 1942–1948.

22.

Hollis

. Measuring 25-hydroxyvitamin D in a clinical environment: Challenges and needs. Am J Clin Nutr 2008; 88: 507S–510S.

23.

Levey

Stevens

Schmid

. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.

24.

R Development Core Team. R: A language and environment for statistical computing, Vienna, Austria: R Foundation for Statistical Computing, 2008.

25.

Geraci

Bottai

. Quantile regression for longitudinal data using the asymmetric Laplace distribution. Biostatistics 2007; 8: 140–154.

26.

Wickham

. Ggplot2: Elegant graphics for data analysis, Dordrecht: Springer, 2009, pp. viii, 212–viii, 212.

27.

Duncan

Talwar

McMillan

. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr 2012; 95: 64–71.

28.

Pittas

Chung

Trikalinos

. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307–314.

29.

Grandi

Breitling

Vossen

. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 2010; 159: 1044–1051.

30.

Bittner

Wenger

Waters

. Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease. Am Heart J 2012; 164: 387–393.

31.

Naesgaard

Leon De La Fuente

Nilsen

. Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PloS One 2012; 7: e43228–e43228.

32.

Lim

Shin

Kim

. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: The Korean Longitudinal Study on Health and Aging. J Clin Endocrinol Metab 2012; 97: 169–178.

33.

Joergensen

Reinhard

Schmedes

. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care 2012; 35: 168–172.

34.

Blondon

Sachs

Hoofnagle

. 25-hydroxyvitamin d and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33: 2639–2645.

35.

Deleskog

Piksasova

Silveira

. Serum 25-hydroxyvitamin d concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33: 2633–2638.

36.

Kiani AN, Fang H, Magder LS, et al. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology 2013; 52: 2071–2076.

37.

Young

Snell-Bergeon

Naik

. Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care 2011; 34: 454–458.

38.

De Boer

Kestenbaum

Shoben

. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009; 20: 1805–1812.

39.

Holick

Binkley

Bischoff-Ferrari

. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911–1930.

40.

Fiscella

Franks

. Vitamin D, race, and cardiovascular mortality: Findings from a national US sample. Ann Fam Med 2010; 8: 11–18.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

32.88 MB

0.23 MB

0.02 MB

Vitamin D status was not associated with ‘one-year’ progression of coronary artery disease,assessed by coronary angiography in statin-treated patients

Abstract

Background

Methods and Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material